Acadia Pharmaceuticals | ACAD - PE Price to Earnings


Acadia Pharmaceuticals reported 11.61 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
ALKERMES 19.54 4.64 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Corcept Therapeutics 41.9 52.28 Dec/2025
Eisai 26.63 0.46 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Incyte 14.84 2.79 Dec/2025
J&J 23.62 0.86 Dec/2025
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 835.47 802.2 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Prothena 22.11 11.37 Mar/2022
PTC Therapeutics 9.98 3.25 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Vertex Pharmaceuticals 26.15 2.22 Dec/2025